Eolo Pharma is a leading drug development and discovery platform company, driven by a dedicated team of scientists and entrepreneurs. Founded as a spin-off from the Institut Pasteur de Montevideo and the Universidad de la República Uruguay, we are focused on developing novel molecules to address non-communicable disorders such as cardiometabolic, neurodegenerative, and autoimmune disorders. With over a decade of experience in working with small molecules, we have built a unique portfolio based on patented technologies and extensive intellectual property licenses.

Our team consists of dynamic and accomplished professionals who bring specialized knowledge and expertise to their roles. Led by Maria Pia Garat, a visionary leader with a strong background in the biotech industry, we have a track record of successful investment rounds that highlight our strategic prowess. Carlos Escande, as our CSO, spearheads our research and development efforts with his extensive knowledge in pharmaceutical research, while Virginia Lopez, also a CSO, contributes her exceptional knowledge and expertise in the field of chemistry.

Carlos Batthyany, our CMO, plays a crucial role in driving our clinical development strategies and ensuring the safety and efficacy of our pharmaceutical products. At Eolo Pharma, we are dedicated to improving the health and well-being of individuals. Our high-quality products are designed to enhance energy and vitality, providing innovative solutions for healthcare.

Join us on this journey to discover a life full of energy and vitality